Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Inductive and Deductive Approaches to Acute Cell Injury.

DeGracia DJ, Tri Anggraini F, Taha DT, Huang ZF.

Int Sch Res Notices. 2014 Oct 13;2014:859341. doi: 10.1155/2014/859341. eCollection 2014. Review.

2.

Fenretinide (4-HPR) Targets Caspase-9, ERK 1/2 and the Wnt3a/β-Catenin Pathway in Medulloblastoma Cells and Medulloblastoma Cell Spheroids.

Bassani B, Bartolini D, Pagani A, Principi E, Zollo M, Noonan DM, Albini A, Bruno A.

PLoS One. 2016 Jul 1;11(7):e0154111. doi: 10.1371/journal.pone.0154111. eCollection 2016.

3.

C/EBP homologous protein (CHOP) deficiency ameliorates renal fibrosis in unilateral ureteral obstructive kidney disease.

Liu SH, Wu CT, Huang KH, Wang CC, Guan SS, Chen LP, Chiang CK.

Oncotarget. 2016 Apr 19;7(16):21900-12. doi: 10.18632/oncotarget.7870.

4.

p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma.

Ganeshan VR, Schor NF.

Cancer Chemother Pharmacol. 2014 Feb;73(2):271-9. doi: 10.1007/s00280-013-2355-y. Epub 2013 Nov 20.

5.

In vitro activities of novel 4-HPR derivatives on a panel of rhabdoid and other tumor cell lines.

Smith ME, Das BC, Kalpana GV.

Cancer Cell Int. 2011 Sep 27;11:34. doi: 10.1186/1475-2867-11-34.

6.

Targeting angiogenesis for controlling neuroblastoma.

Roy Choudhury S, Karmakar S, Banik NL, Ray SK.

J Oncol. 2012;2012:782020. doi: 10.1155/2012/782020. Epub 2011 Aug 25.

7.

Pharmacologic management of high-risk neuroblastoma in children.

Ganeshan VR, Schor NF.

Paediatr Drugs. 2011 Aug 1;13(4):245-55. doi: 10.2165/11591630-000000000-00000. Review.

8.

Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1.

Xu YZ, Heravi M, Thuraisingam T, Di Marco S, Muanza T, Radzioch D.

Mol Cancer. 2010 Aug 5;9:210. doi: 10.1186/1476-4598-9-210.

9.

Survivin knockdown and concurrent 4-HPR treatment controlled human glioblastoma in vitro and in vivo.

George J, Banik NL, Ray SK.

Neuro Oncol. 2010 Nov;12(11):1088-101. doi: 10.1093/neuonc/noq079. Epub 2010 Aug 2.

10.

Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma.

Cuperus R, Leen R, Tytgat GA, Caron HN, van Kuilenburg AB.

Cell Mol Life Sci. 2010 Mar;67(5):807-16. doi: 10.1007/s00018-009-0212-2. Epub 2009 Nov 26.

11.

The apoptotic machinery as a biological complex system: analysis of its omics and evolution, identification of candidate genes for fourteen major types of cancer, and experimental validation in CML and neuroblastoma.

Di Pietro C, Ragusa M, Barbagallo D, Duro LR, Guglielmino MR, Majorana A, Angelica R, Scalia M, Statello L, Salito L, Tomasello L, Pernagallo S, Valenti S, D'Agostino V, Triberio P, Tandurella I, Palumbo GA, La Cava P, Cafiso V, Bertuccio T, Santagati M, Li Destri G, Lanzafame S, Di Raimondo F, Stefani S, Mishra B, Purrello M.

BMC Med Genomics. 2009 Apr 30;2:20. doi: 10.1186/1755-8794-2-20.

12.

New approaches to pharmacotherapy of tumors of the nervous system during childhood and adolescence.

Schor NF.

Pharmacol Ther. 2009 Apr;122(1):44-55. doi: 10.1016/j.pharmthera.2009.01.001. Epub 2009 Jan 23. Review.

Supplemental Content

Support Center